BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yao BR, Sun Y, Chen SL, Suo HD, Zhang YL, Wei H, Wang CH, Zhao F, Cong W, Xin WY, Hou GG. Dissymmetric pyridyl-substituted 3,5-bis(arylidene)-4-piperidones as anti-hepatoma agents by inhibiting NF-κB pathway activation. Eur J Med Chem 2019;167:187-99. [PMID: 30771605 DOI: 10.1016/j.ejmech.2019.02.020] [Cited by in Crossref: 27] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Wang A, Gao R, Luan Q, Wang Z, Li X, Hou G. Crystal structure and anti-inflammatory activity of (3 E ,5 E )-3-(2-fluorobenzylidene)-1-((4-acetamidophenyl)sulfonyl)-5-(pyridin-3-ylmethylene)piperidin-4-one-methanol-hydrate (2/1/1), C 53 H 50 F 2 N 6 O 10 S 2. Zeitschrift für Kristallographie - New Crystal Structures 2020;235:381-4. [DOI: 10.1515/ncrs-2019-0686] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
2 Su X, Zhang X, Meng Q, Li H. Crystal structure of ( E )-7-fluoro-2-((6-methoxypyridin-3-yl)methylene)-3,4-dihydronaphthalen-1(2 H )-one, C 17 H 14 FNO 2. Zeitschrift für Kristallographie - New Crystal Structures 2021;236:1101-3. [DOI: 10.1515/ncrs-2021-0236] [Reference Citation Analysis]
3 Zhang J, Chen D, Lv L, Qi C, Xu W, Hou G. Crystal structure and anti-inflammatory activity of (3 E ,5 E )-3,5-bis(2-fluorobenzylidene)-1-((4-fluorophenyl)sulfonyl)piperidin-4-one, C 25 H 18 F 3 NO 3 S. Zeitschrift für Kristallographie - New Crystal Structures 2020;235:1051-3. [DOI: 10.1515/ncrs-2020-0165] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Cong W, Sun Y, Sun YF, Yan WB, Zhang YL, Gao ZF, Wang CH, Hou GG, Zhang JJ. Trifluoromethyl-substituted 3,5-bis(arylidene)-4-piperidones as potential anti-hepatoma and anti-inflammation agents by inhibiting NF-кB activation. J Enzyme Inhib Med Chem 2021;36:1622-31. [PMID: 34284695 DOI: 10.1080/14756366.2021.1953996] [Reference Citation Analysis]
5 Sun Y, Gao ZF, Yan WB, Yao BR, Xin WY, Wang CH, Meng QG, Hou GG. Discovery of novel NF-кB inhibitor based on scaffold hopping: 1,4,5,6,7,8-hexahydropyrido[4,3-d]pyrimidine. Eur J Med Chem 2020;198:112366. [PMID: 32371335 DOI: 10.1016/j.ejmech.2020.112366] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 3.5] [Reference Citation Analysis]
6 Watanabe M, Sugawara A, Noguchi Y, Hirose T, Ōmura S, Sunazuka T, Horie R. Jietacins, azoxy natural products, as novel NF-κB inhibitors: Discovery, synthesis, biological activity, and mode of action. Eur J Med Chem 2019;178:636-47. [PMID: 31226655 DOI: 10.1016/j.ejmech.2019.05.079] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
7 Zhang S, Zhao F, Meng Q. Crystal structure of ( E )-7-hydroxy-2-((6-methoxypyridin-3-yl)methylene)-3, 4-dihydronaphthalen-1(2 H )-one, C 17 H 15 NO 3. Zeitschrift für Kristallographie - New Crystal Structures 2022;237:1-3. [DOI: 10.1515/ncrs-2021-0382] [Reference Citation Analysis]
8 Wu DL, Liao ZD, Chen FF, Zhang W, Ren YS, Wang CC, Chen XX, Peng DY, Kong LY. Benzophenones from Anemarrhena asphodeloides Bge. Exhibit Anticancer Activity in HepG2 Cells via the NF-κB Signaling Pathway. Molecules 2019;24:E2246. [PMID: 31208101 DOI: 10.3390/molecules24122246] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
9 Luan M, Meng Q. Crystal structure of ( E )-7-methoxy-2-((5-methoxypyridin-3-yl)methylene)-3,4- dihydronaphthalen-1(2 H )-one, C 18 H 17 NO 3. Zeitschrift für Kristallographie - New Crystal Structures 2021;236:387-9. [DOI: 10.1515/ncrs-2020-0602] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
10 Su CM, Hou GG, Wang CH, Zhang HQ, Yang C, Liu M, Hou Y. Potential multifunctional agents with anti-hepatoma and anti-inflammation properties by inhibiting NF-кB activation. J Enzyme Inhib Med Chem 2019;34:1287-97. [PMID: 31288582 DOI: 10.1080/14756366.2019.1635124] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 5.3] [Reference Citation Analysis]
11 Zhang X, Wang H, Song J, Liang L, Xu Y, Zhao F, Meng Q. Crystal structure of (3 E ,5 E )-3,5-bis-4-methoxy-3-(trifluoromethyl)benzylidene)-1-methylpiperidin-4-one, C 24 H 21 F 6 NO 3. Zeitschrift für Kristallographie - New Crystal Structures 2021;236:209-11. [DOI: 10.1515/ncrs-2020-0492] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Yan W, Liu Y, Hou G, Cong W, Meng Q. Crystal structure and anti-inflammatory activity of (3 E ,5 E )-3,5-bis(4-fluorobenzylidene)-1-((4-fluorophenyl)sulfonyl)piperidin-4-one-dichloromethane (1/1), C 26 H 20 Cl 2 F 3 NO 3 S. Zeitschrift für Kristallographie - New Crystal Structures 2020;235:947-9. [DOI: 10.1515/ncrs-2020-0116] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Sun J, Zhang X, Meng Q, Li H, Wang C. Crystal structure and anti-inflammatory activity of ( E )-7-fluoro-2-((5-methoxypyridin-3-yl)methylene)-3,4-dihydronaphthalen-1(2 H )-one, C 17 H 14 FNO 2. Zeitschrift für Kristallographie - New Crystal Structures 2021;236:1097-9. [DOI: 10.1515/ncrs-2021-0234] [Reference Citation Analysis]
14 Zhou YQ, Sun Y, Luo HL, Gao ZF, Zhang HQ, Meng QG, Bai XY, Hou GG, Hou Y. Discovery of anti-hepatoma agents from 1,4,5,6,7,8-hexahydropyrido[4,3-d]pyrimidine by inhibiting PI3K/AKT/NF-κB pathway activation. Eur J Med Chem 2021;225:113796. [PMID: 34450496 DOI: 10.1016/j.ejmech.2021.113796] [Reference Citation Analysis]
15 Bian M, Ma QQ, Wu Y, Du HH, Guo-Hua G. Small molecule compounds with good anti-inflammatory activity reported in the literature from 01/2009 to 05/2021: a review. J Enzyme Inhib Med Chem 2021;36:2139-59. [PMID: 34628990 DOI: 10.1080/14756366.2021.1984903] [Reference Citation Analysis]
16 Liu H, Fafeng, Cheng, Tang F, Wang Y, Liu S, Wang X. Paeoniflorin inhibits lipopolysaccharide-induced inflammation in LO2 cells by regulating RhoA/NLRP3 pathway. Journal of Traditional Chinese Medical Sciences 2021;8:161-5. [DOI: 10.1016/j.jtcms.2021.06.001] [Reference Citation Analysis]
17 Sun Y, Zhou YQ, Liu YK, Zhang HQ, Hou GG, Meng QG, Hou Y. Potential anti-neuroinflammatory NF-кB inhibitors based on 3,4-dihydronaphthalen-1(2H)-one derivatives. J Enzyme Inhib Med Chem 2020;35:1631-40. [PMID: 32781863 DOI: 10.1080/14756366.2020.1804899] [Cited by in Crossref: 11] [Cited by in F6Publishing: 1] [Article Influence: 11.0] [Reference Citation Analysis]
18 Qian ZJ, Chen MF, Chen J, Zhang Y, Zhou C, Hong P, Yang P. Intracellular ethanol-mediated oxidation and apoptosis in HepG2/CYP2E1 cells impaired by two active peptides from seahorse (Hippocampus kuda bleeler) protein hydrolysates via the Nrf2/HO-1 and akt pathways. Food Sci Nutr 2021;9:1584-602. [PMID: 33747471 DOI: 10.1002/fsn3.2133] [Reference Citation Analysis]
19 Sun Y, Gao Z, Wang C, Hou G. Synthesis, crystal structures and anti-inflammatory activity of fluorine-substituted 1,4,5,6-tetrahydrobenzo[h]quinazolin-2-amine derivatives. Acta Crystallogr C Struct Chem 2019;75:1157-65. [PMID: 31380799 DOI: 10.1107/S2053229619010118] [Cited by in Crossref: 13] [Cited by in F6Publishing: 1] [Article Influence: 4.3] [Reference Citation Analysis]
20 Song J, Zhao F, Wang Q, Meng Q. Crystal structure of ( E )-7-fluoro-2-(3-fluorobenzylidene)-3,4-dihydronaphthalen-1(2 H )-one, C 17 H 12 F 2 O 1. Zeitschrift für Kristallographie - New Crystal Structures 2022;237:55-7. [DOI: 10.1515/ncrs-2021-0392] [Reference Citation Analysis]
21 Bai X, Meng Q, Hou G, Hou Y. Crystal structure and anti-inflammatory activity of (3 E ,5 E )-1-((4-bromophenyl)sulfonyl)-3-(pyridin-4-ylmethylene)-5-(2-(trifluoromethyl)benzylidene)piperidin-4-one, C 25 H 18 BrF 3 N 2 O 3 S. Zeitschrift für Kristallographie - New Crystal Structures 2020;235:407-9. [DOI: 10.1515/ncrs-2019-0715] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
22 Sun Y, Wang S, Hou G. Crystal structure of (3 E ,5 E )-3,5-bis(3-nitrobenzylidene)-1-((4-(trifluoromethyl)phenyl)sulfonyl)piperidin-4-one — dichloromethane (2/1), C 53 H 38 Cl 2 F 6 N 6 O 14 S 2. Zeitschrift für Kristallographie - New Crystal Structures 2019;234:1047-9. [DOI: 10.1515/ncrs-2019-0253] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
23 Zhou Y, Hou G, Meng Q, Hou Y. Crystal structure and anti-inflammatory activity of (3 E ,5 E )-1-((4-chlorophenyl)sulfonyl)-3-(pyridin-4-ylmethylene)-5-(2-(trifluoromethyl)benzylidene)piperidin-4-one, C 25 H 18 ClF 3 N 2 O 3 S. Zeitschrift für Kristallographie - New Crystal Structures 2020;235:411-3. [DOI: 10.1515/ncrs-2019-0716] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]